Published in Medical Devices and Surgical Technology Week, August 31st, 2003
Professor Xumu Zhang, Chiral Quest's chief technology officer is the inventor on the patent. Chiral Quest, Inc., is the exclusive licensee of the patent.
DIOP ligand differs from well-known DIOP ligand in its conformational stability. Methyl groups and other substituents in DIOP are oriented in equatorial positions. This conformational difference has produced a dramatic increase of enantioselectivity for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.